Cotinga Pharmaceuticals Companies

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company’s lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene.COTQF Cotinga Pharmaceuticals Inc. - Seeking Alphaseekingalpha.com/symbol/COTQF

Industry: AI R&D Pharma (DPI)
Headquarters: Boston, Suffolk County, Massachusetts, United States
Founded Date: 1999
Employee Number: 11-50